Literature DB >> 19795441

Synthesis and fungicidal activity of tubulin polymerisation promoters. Part 1: pyrido[2,3-b]pyrazines.

Patrick J Crowley1, Clemens Lamberth, Urs Müller, Sebastian Wendeborn, Kurt Nebel, John Williams, Olivia-A Sageot, Neil Carter, Tanya Mathie, Hans-Joachim Kempf, Jeremy Godwin, Peter Schneiter, Markus R Dobler.   

Abstract

BACKGROUND: The excellent fungicidal activity of [1,2,4]triazolo[1,5-a]pyrimidines suggested the search for further analogues with improved properties.
RESULTS: A series of novel trisubstituted pyrido[2,3-b]pyrazines has been designed and prepared as 6,6-biheterocyclic analogues of related 5,6-bicyclic [1,2,4]triazolo[1,5-a]pyrimidines. Their fungicidal activity was evaluated against the plant pathogens Puccinia recondita Rob. ex Desm. f. sp. tritici (Eriks.) CO Johnston (wheat brown rust), Mycosphaerella graminicola (Fuckel) Schroter (Septoria tritici Rob., leaf spot of wheat) and Magnaporthe grisea (Hebert) Barr (Pyricularia oryzae Cav., rice blast). Structure-activity relationship studies revealed the advantage of a fluoro substituent in position 6 and of a secondary amine in position 8.
CONCLUSION: 8-Amino-7-aryl-6-halogen-substituted pyrido[2,3-b]pyrazines have been prepared as 6,6-biheterocyclic analogues of similarly substituted triazolopyrimidine fungicides. A concise four-step synthesis route has been worked out to prepare these novel compounds from commercially available starting materials. [(R)-(1,2-Dimethylpropyl)]-[6-fluoro-7-(2,4,6-trifluorophenyl)pyrido[2,3-b]pyrazin-8-yl]amine showed excellent activity against three economically important phytopathogens.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 19795441     DOI: 10.1002/ps.1852

Source DB:  PubMed          Journal:  Pest Manag Sci        ISSN: 1526-498X            Impact factor:   4.845


  5 in total

1.  Pharmacokinetic, pharmacodynamic and metabolic characterization of a brain retentive microtubule (MT)-stabilizing triazolopyrimidine.

Authors:  Anne-Sophie Cornec; Michael J James; Jane Kovalevich; John Q Trojanowski; Virginia M-Y Lee; Amos B Smith; Carlo Ballatore; Kurt R Brunden
Journal:  Bioorg Med Chem Lett       Date:  2015-03-14       Impact factor: 2.823

Review 2.  Microtubule stabilizing agents as potential treatment for Alzheimer's disease and related neurodegenerative tauopathies.

Authors:  Carlo Ballatore; Kurt R Brunden; Donna M Huryn; John Q Trojanowski; Virginia M-Y Lee; Amos B Smith
Journal:  J Med Chem       Date:  2012-09-28       Impact factor: 7.446

3.  Brain-Penetrant Triazolopyrimidine and Phenylpyrimidine Microtubule Stabilizers as Potential Leads to Treat Human African Trypanosomiasis.

Authors:  Ludovica Monti; Steven C Wang; Killian Oukoloff; Amos B Smith; Kurt R Brunden; Conor R Caffrey; Carlo Ballatore
Journal:  ChemMedChem       Date:  2018-08-07       Impact factor: 3.466

4.  Congeners Derived from Microtubule-Active Phenylpyrimidines Produce a Potent and Long-Lasting Paralysis of Schistosoma mansoni In Vitro.

Authors:  Ludovica Monti; Anne-Sophie Cornec; Killian Oukoloff; Jane Kovalevich; Kristen Prijs; Thibault Alle; Kurt R Brunden; Amos B Smith; Nelly El-Sakkary; Lawrence J Liu; Ali Syed; Danielle E Skinner; Carlo Ballatore; Conor R Caffrey
Journal:  ACS Infect Dis       Date:  2020-10-31       Impact factor: 5.084

5.  Brain-penetrant, orally bioavailable microtubule-stabilizing small molecules are potential candidate therapeutics for Alzheimer's disease and related tauopathies.

Authors:  Kevin Lou; Yuemang Yao; Adam T Hoye; Michael J James; Anne-Sophie Cornec; Edward Hyde; Bryant Gay; Virginia M-Y Lee; John Q Trojanowski; Amos B Smith; Kurt R Brunden; Carlo Ballatore
Journal:  J Med Chem       Date:  2014-07-03       Impact factor: 7.446

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.